Apeloa Pharmaceutical Co.,Ltd
SHZ: 000739.SZ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shenzhen Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Fangmeng Zhu
- Employees
- 7,060
- Headquarters
- Dongyang, China
- IPO year
- 1997
- Market cap
- CN¥20.3B
- Website
- https://www.apeloa.com
Loading 000739…
Loading profile data…Frequently asked questions about 000739
What does Apeloa Pharmaceutical Co.,Ltd (000739.SZ) do?
Apeloa Pharmaceutical Co.,Ltd researches and develops, produces, and sells pharmaceutical products in China and internationally. It provides products in the cardio-cerebrovascular, anti-infection, anti-viral, anti-tumor, and other treatment areas. The company offers preparations, raw material intermediates, and veterinary drugs primarily under t...
Where does 000739.SZ trade?
Apeloa Pharmaceutical Co.,Ltd (000739.SZ) trades on the Shenzhen Stock Exchange.
What sector is 000739.SZ in?
Apeloa Pharmaceutical Co.,Ltd (000739.SZ) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Apeloa Pharmaceutical Co.,Ltd?
Fangmeng Zhu is the chief executive officer of Apeloa Pharmaceutical Co.,Ltd (000739.SZ).
Where is Apeloa Pharmaceutical Co.,Ltd headquartered?
Apeloa Pharmaceutical Co.,Ltd is headquartered in China.
Does 000739.SZ pay a dividend?
Yes — Apeloa Pharmaceutical Co.,Ltd (000739.SZ) paid a trailing twelve-month dividend of CNY 0.94 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 000739.SZ go public?
Apeloa Pharmaceutical Co.,Ltd (000739.SZ) completed its initial public offering in 1997.